Oprah Winfrey To Spotlight Weight Loss Drugs In New TV Special: Will 'Shame, Blame' Come To Drug Companies — Or Could They Get Another Lift?
Portfolio Pulse from Chris Katje
Oprah Winfrey is set to air a TV special on ABC, focusing on weight loss drugs, their benefits, and potential side effects. The special, following her departure from WeightWatchers' board, could impact the perception of weight loss drugs. Companies like Novo Nordisk and Eli Lilly, behind popular weight loss drugs Ozempic, Wegovy, and Mounjaro, could see their stocks influenced by the special's reception. The special will also be available on Hulu, a streaming platform owned by Walt Disney Co.
March 08, 2024 | 9:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Walt Disney Co, owning ABC and Hulu, will air Oprah's special on weight loss drugs, potentially boosting viewership and stock.
The airing of Oprah's special on Disney's ABC and Hulu could attract a significant viewership, positively impacting Disney's stock due to increased exposure and potential advertising revenue.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Eli Lilly, maker of Mounjaro, could see stock volatility depending on the portrayal of weight loss drugs in Oprah's special.
Given the significant market value of Eli Lilly and the popularity of Mounjaro, the company's stock could experience short-term volatility based on the special's content and public reception.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
NEUTRAL IMPACT
Novo Nordisk, behind Ozempic and Wegovy, faces potential stock impact from Oprah's special on weight loss drugs.
As Novo Nordisk's weight loss drugs are highlighted, the company's stock might see fluctuations depending on whether the special casts these drugs in a predominantly positive or negative light.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
WW International may see further stock movement following Oprah's special on weight loss drugs after her departure from the board.
Oprah's departure from WeightWatchers and her focus on pharmaceutical weight loss solutions could negatively impact WW International's stock as it may shift consumer preference away from their services.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80